We are live on
!
Find out more
KA
Kintegral Advisory Portfolio holdings
AUM
$1.06B
1-Year Est. Return
24.93%
This Fund
S&P 500
This Quarter
Est. Return
+22.93%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
–
AUM
$622M
AUM Growth
+$108M
(+21%)
Cap. Flow
+$729K
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
32.46%
Holding
269
New
8
Increased
1
Reduced
–
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corning
GLW
|
+$514K |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$303K |
| 3 |
AbbVie
ABBV
|
+$298K |
| 4 |
LyondellBasell Industries
LYB
|
+$236K |
| 5 |
Darden Restaurants
DRI
|
+$224K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$693K |
| 2 |
Owens Corning
OC
|
+$465K |
| 3 |
Warner Bros
WBD
|
+$271K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Healthcare | 14.34% |
| 3 | Financials | 11.48% |
| 4 | Communication Services | 11.03% |
| 5 | Consumer Staples | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amgen
AMGN
$198B
| $5.38M | 0.86% |
22,797
| – | – |
|
|
MRSH
27
Marsh
MRSH
$84B
| $5.28M | 0.85% |
49,153
| – | – |
|
28
Zoetis
ZTS
$31B
| $5.11M | 0.82% |
37,303
| – | – |
|
29
American Tower
AMT
$77.7B
| $5.01M | 0.81% |
19,286
| – | – |
|
30
Verizon
VZ
$184B
| $4.9M | 0.79% |
88,867
| – | – |
|
31
Coca-Cola
KO
$348B
| $4.73M | 0.76% |
104,805
| – | – |
|
32
Netflix
NFLX
$286B
| $4.46M | 0.72% |
97,990
| – | – |
|
33
Johnson & Johnson
JNJ
$622B
| $4.38M | 0.7% |
31,116
| – | – |
|
34
Vertex Pharmaceuticals
VRTX
$121B
| $4.2M | 0.68% |
14,476
| – | – |
|
35
American Express
AXP
$233B
| $4.18M | 0.67% |
43,929
| – | – |
|
36
Visa
V
$667B
| $4.01M | 0.65% |
20,786
| – | – |
|
37
McDonald's
MCD
$187B
| $3.98M | 0.64% |
21,604
| – | – |
|
38
Bristol-Myers Squibb
BMY
$126B
| $3.83M | 0.62% |
65,091
| – | – |
|
39
Autodesk
ADSK
$43.1B
| $3.74M | 0.6% |
15,651
| – | – |
|
40
JPMorgan Chase
JPM
$927B
| $3.66M | 0.59% |
38,949
| – | – |
|
41
Gilead Sciences
GILD
$161B
| $3.57M | 0.57% |
46,386
| – | – |
|
42
Clorox
CLX
$11.4B
| $3.55M | 0.57% |
16,176
| – | – |
|
43
Union Pacific
UNP
$181B
| $3.54M | 0.57% |
20,954
| – | – |
|
44
Caterpillar
CAT
$419B
| $3.54M | 0.57% |
27,986
| – | – |
|
45
Cummins
CMI
$92.5B
| $3.5M | 0.56% |
20,218
| – | – |
|
46
Northern Trust
NTRS
$21.9B
| $3.5M | 0.56% |
43,729
| – | – |
|
|
TIF
47
DELISTED
Tiffany & Co.
TIF
| $3.49M | 0.56% |
28,341
| – | – |
|
48
Best Buy
BBY
$17.8B
| $3.48M | 0.56% |
39,593
| – | – |
|
49
IBM
IBM
$195B
| $3.39M | 0.54% |
29,323
| – | – |
|
50
Linde
LIN
$234B
| $3.35M | 0.54% |
15,789
| – | – |
|
Similar funds
MWA
SFP
CA
MFS
ECM
NRG
HW
LAM
Kintegral Advisory's Q2 2020 Portfolio in Review
As of Q2 2020, Kintegral Advisory held 269 positions worth $622M, up 21% from $513M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q2 2020: portfolio turnover was 4.1%. Kintegral Advisory opened 8 new positions and exited 3, leaving the 269-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- Kintegral Advisory's largest Q2 2020 buy was Corning: 22,663 shares worth $587K.
- Kintegral Advisory added most to AbbVie in Q2 2020, an estimated $298K increase.
- Kintegral Advisory fully exited Allergan plc in Q2 2020, selling an estimated $693K.
- Kintegral Advisory's ten largest holdings make up 32% of its $622M portfolio in Q2 2020.
- Kintegral Advisory opened 8 new positions and closed 3 in Q2 2020.
- Kintegral Advisory's portfolio value rose 21% quarter-over-quarter to $622M.
Based on Kintegral Advisory's 13F filing for Q2 2020, filed 12 Aug 2020.